Article
Viral decline over 48h and HCV amino acid mutations are related to efficacy of PEG-IFN/ribavirin.
Hepato-gastroenterology - 1 May 2012
Miyasaka Akio, Kumagai Ichiro, Abe Koichi, Suzuki Kazuyuki
Abstract excerpt
BACKGROUND/AIMS: The relationship between mutations and HCV dynamics has not been fully studied in terms of the efficacy of PEG-IFN/Rib combination treatment. Here we aimed to systematically examine HCV dynamics during PEG-IFN/Rib treatment and evaluate the association between amino acid (aa) substitutions in HCV and efficacy of PEG-IFN/Rib treatment. METHODOLOGY: Patients (n=36) having HCV genotype 1b infection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
